Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Avdeev

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Terapevticheskii Arkhiv|July 27, 2016
[The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension]S N Avdeev
Terapevticheskii Arkhiv|November 24, 2015
[Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan]S N Avdeev
Terapevticheskii Arkhiv|June 22, 2017
[Idiopatic pulmonary fibrosis: A new paradigm]S N Avdeev
Terapevticheskii Arkhiv|March 14, 2013
[Current guidelines for oxygen therapy in emergency care]S N Avdeev
Terapevticheskii Arkhiv|April 30, 2014
[Choice of novel endpoints in clinical trials evaluating the efficiency of drug therapy in patients with pulmonary hypertension]S N Avdeev
Herald of the Russian Academy of Sciences|September 12, 2022
COVID-19: Opportunities to Improve PrognosisS N Avdeev
Terapevticheskii Arkhiv|May 17, 2019
New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary diseaseS N Avdeev, N V Trushenko
Terapevticheskii Arkhiv|May 17, 2019
Possibilities of ultrasound research of the diaphragmG V Nekludova, S N Avdeev
Kardiologiia|January 10, 2019
N A Tsareva, S N Avdeev
Kardiologiia|July 20, 2019
[Novel Biomarkers of Pulmonary Hypertension]V V Gaynitdinova, S N Avdeev
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Terapevticheskii Arkhiv|July 27, 2016
[The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension]S N Avdeev
Terapevticheskii Arkhiv|November 24, 2015
[Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan]S N Avdeev
Terapevticheskii Arkhiv|June 22, 2017
[Idiopatic pulmonary fibrosis: A new paradigm]S N Avdeev
Terapevticheskii Arkhiv|March 14, 2013
[Current guidelines for oxygen therapy in emergency care]S N Avdeev
Terapevticheskii Arkhiv|April 30, 2014
[Choice of novel endpoints in clinical trials evaluating the efficiency of drug therapy in patients with pulmonary hypertension]S N Avdeev
Herald of the Russian Academy of Sciences|September 12, 2022
COVID-19: Opportunities to Improve PrognosisS N Avdeev
Terapevticheskii Arkhiv|May 17, 2019
New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary diseaseS N Avdeev, N V Trushenko
Terapevticheskii Arkhiv|May 17, 2019
Possibilities of ultrasound research of the diaphragmG V Nekludova, S N Avdeev
Kardiologiia|January 10, 2019
N A Tsareva, S N Avdeev
Kardiologiia|July 20, 2019
[Novel Biomarkers of Pulmonary Hypertension]V V Gaynitdinova, S N Avdeev
Pageof 7